Shawn Cross

Shawn joined AMT as chief financial officer in 2020 where he leads the company’s finance strategy and oversees financial operations. He brings over 20 years of biopharmaceutical strategic advisory and capital market experience. Prior to joining AMT, Mr. Cross was at JMP Securities where he served as managing director and co-head of healthcare investment banking. Previously, Shawn held various investment banking roles at top financial institutions in New York, London and San Francisco including managing director in healthcare investment banking at Deutsche Bank Securities, managing director and head of biopharmaceutical investment banking at Wells Fargo Securities, amongst others. He also brings operational experience from his time on the executive management team at GT Biopharma, a targeted immunotherapies company. Shawn holds an M.B.A. from Columbia Business School and a B.S. from the University of California, Los Angeles.